Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;16(6):e0245312.
doi: 10.1371/journal.pone.0245312. eCollection 2021.

IHR-PVS National Bridging Workshops, a tool to operationalize the collaboration between human and animal health while advancing sector-specific goals in countries

Guillaume Belot  1 , François Caya  2 , Kaylee Myhre Errecaborde  1 , Tieble Traore  3 , Brice Lafia  4 , Artem Skrypnyk  5 , Djhane Montabord  6 , Maud Carron  2 , Susan Corning  2 , Rajesh Sreedharan  1 , Nicolas Isla  5 , Tanja Schmidt  5 , Gyanendra Gongal  7 , Dalia Samhouri  8 , Enrique Perez-Gutierrez  9 , Ana Riviere-Cinnamond  9 , Jun Xing  1 , Stella Chungong  1 , Stephane de la Rocque  1
Affiliations

IHR-PVS National Bridging Workshops, a tool to operationalize the collaboration between human and animal health while advancing sector-specific goals in countries

Guillaume Belot et al. PLoS One. .

Abstract

Collaborative, One Health approaches support governments to effectively prevent, detect and respond to emerging health challenges, such as zoonotic diseases, that arise at the human-animal-environmental interfaces. To overcome these challenges, operational and outcome-oriented tools that enable animal health and human health services to work specifically on their collaboration are required. While international capacity and assessment frameworks such as the IHR-MEF (International Health Regulations-Monitoring and Evaluation Framework) and the OIE PVS (Performance of Veterinary Services) Pathway exist, a tool and process that could assess and strengthen the interactions between human and animal health sectors was needed. Through a series of six phased pilots, the IHR-PVS National Bridging Workshop (NBW) method was developed and refined. The NBW process gathers human and animal health stakeholders and follows seven sessions, scheduled across three days. The outputs from each session build towards the next one, following a structured process that goes from gap identification to joint planning of corrective measures. The NBW process allows human and animal health sector representatives to jointly identify actions that support collaboration while advancing evaluation goals identified through the IHR-MEF and the OIE PVS Pathway. By integrating sector-specific and collaborative goals, the NBWs help countries in creating a realistic, concrete and practical joint road map for enhanced compliance to international standards as well as strengthened preparedness and response for health security at the human-animal interface.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The IHR-PVS matrix is a 5x3 meter presentation stand used by participants during the NBW.
The matrix crosses the indicators from the IHR-MEF in rows and the Critical Competencies of the PVS Pathway in columns. Two versions of the matrix exist regarding the IHR-MEF: one with SPAR indicators and one with JEE indicators. The matrix was produced in English, French, Russian and Spanish versions.
Fig 2
Fig 2. Example of an extract from a NBW roadmap (Serbia, November 2019).
The full roadmap contains 11 specific objectives and 27 activities.
Fig 3
Fig 3. The NBW material tool-kit comprises posters, technical cards, fact sheets, stationary supplies and a facilitator manual.
The tool-kit is provided by WHO and OIE headquarters. The participant handbooks and assessment (SPAR/JEE, PVS) reports are printed locally.
See this image and copyright information in PMC

References

    1. Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci. 2001;356(1411):983–9. 10.1098/rstb.2001.0888 - DOI - PMC - PubMed
    1. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–3. 10.1038/nature06536 - DOI - PMC - PubMed
    1. Weber DJ, Rutala WA, Fischer WA, Kanamori H, Sickbert-Bennett EE. Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9). Am J Infect Control. 2016;44(5 Suppl):e91–e100. 10.1016/j.ajic.2015.11.018 - DOI - PMC - PubMed
    1. Morens DM, Fauci AS. Emerging Pandemic Diseases: How We Got to COVID-19. Cell. 2020;182(5):1077–92. 10.1016/j.cell.2020.08.021 - DOI - PMC - PubMed
    1. Daszak P, Cunningham AA, Hyatt AD. Emerging infectious diseases of wildlife—threats to biodiversity and human health. Science. 2000;287(5452):443–9. 10.1126/science.287.5452.443 - DOI - PubMed

Publication types